Report on the risk assessment of 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in the framework of the Council Decision on new psychoactive substances 14. May 2018, section EUDA news
13. February 2026 Action on drug precursors: first EU-level precursor assessment reports published Illicit drug production poses a growing threat to public health and security in Europe. Monitoring drug precursor markets...
